Euro Diagnostica facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. By offering versatile assay solutions to pharma, biotech and CRO customers Euro Diagnostica is an optimal partner in drug development from the exploratory phase to and beyond clinical trials. We also provide clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring and treatment of inflammatory and related diseases.
Top quality ELISA and RIA kits: Key products in our radioimmunoassay- and enzyme-linked immunosorbent assay portfolio are ANCA, anti-CCP 2, chromogranin and complement assay kits, which are developed in collaboration with our world class scientists and key opinion leaders. Most of our ELISA kits are harmonized for automation on the Dynex systems.
Unique Cell-based Assays: Our iLite® platform is based on reporter gene technology and available for our customers, mainly within the pharma and biotech industry, in the form of assay ready frozen cells (off-the-shelf) and as custom cell line development. The same cell line can be used both for assessment of drug potency and for detection of neutralizing antibodies (NAbs) against the specific drug target.
Custom Solutions and OEM: With 20 years of experience we provide optimized development and production processes. Since we combine R&D, manufacturing and administration under one roof in Malmö, Sweden, we are able to offer our customers a reliable and economical solution for their assay development and manufacturing needs.
Dedicated Laboratory Services: Our in-house laboratory Wieslab offers both clinical diagnostic testing, as well as a wide range of bioanalytical services for non-clinical as well as clinical studies for pharma, biotech and CRO customers. All services are performed in an ISO 17025, GCP and GLP compliant environment ensuring that regulatory requirements are met.